Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,633 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expression of PAWR predicts prognosis of ovarian cancer.
Tan J, Tao K, Zheng X, Liu D, Ma D, Gao Q. Tan J, et al. Among authors: tao k. Cancer Cell Int. 2020 Dec 14;20(1):598. doi: 10.1186/s12935-020-01704-y. Cancer Cell Int. 2020. PMID: 33317551 Free PMC article.
Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors.
Luo Y, Xia Y, Liu D, Li X, Li H, Liu J, Zhou D, Dong Y, Li X, Qian Y, Xu C, Tao K, Li G, Pan W, Zhong Q, Liu X, Xu S, Wang Z, Liu R, Zhang W, Shan W, Fang T, Wang S, Peng Z, Jin P, Jin N, Shi S, Chen Y, Wang M, Jiao X, Luo M, Gong W, Wang Y, Yao Y, Zhao Y, Huang X, Ji X, He Z, Zhao G, Liu R, Wu M, Chen G, Hong L; COCPO Consortium; Ma D, Fang Y, Liang H, Gao Q. Luo Y, et al. Among authors: tao k. Cell. 2024 Sep 5;187(18):4905-4925.e24. doi: 10.1016/j.cell.2024.06.013. Epub 2024 Jul 5. Cell. 2024. PMID: 38971151 Free article. Clinical Trial.
Sintilimab combined with bevacizumab in relapsed or persistent ovarian clear cell carcinoma (INOVA): a multicentre, single-arm, phase 2 trial.
Peng Z, Li H, Gao Y, Sun L, Jiang J, Xia B, Huang Y, Zhang Y, Xia Y, Zhang Y, Shen Y, Huang B, Nie J, Chen X, Liu X, Feng C, Li Z, Zhang W, Tao K, Zhang Q, Duan S, Chen Y, Chen Y, Wang W, Zheng H, Lu Y, Liu Y, Wang L, Qi W, He Y, Tian Y; NUWA Platform Research Group; Li G, Ma D, Gao Q. Peng Z, et al. Among authors: tao k. Lancet Oncol. 2024 Oct;25(10):1288-1297. doi: 10.1016/S1470-2045(24)00437-6. Epub 2024 Sep 11. Lancet Oncol. 2024. PMID: 39276785 Clinical Trial.
[Analysis of the efficacy of adjusting the dose of imatinib with therapeutic drug monitoring in adjuvant treatment after complete resection of gastrointestinal stromal tumors].
Chen ZL, Tian HK, Ding JN, Li ZY, Mao G, Du YY, Shen Q, Zhou H, Han Y, Zeng XY, Tao KX, Zhang P. Chen ZL, et al. Among authors: tao kx. Zhonghua Wei Chang Wai Ke Za Zhi. 2024 Nov 25;27(11):1148-1154. doi: 10.3760/cma.j.cn441530-20240807-00273. Zhonghua Wei Chang Wai Ke Za Zhi. 2024. PMID: 39572180 Chinese.
1,633 results